China Approves NEO Brain Implant for Paralysis Recovery, marking a breakthrough in spinal cord injury treatment. This new brain-computer interface (BCI) helps patients regain movement by translating thought into action. The NEO brain implant allows users to perform simple tasks, making daily life easier for those with paralysis or neck injuries.
Developed by Neuracle Medical Technology, the NEO implant uses motor cortex electrodes to capture neural signals. When a patient imagines movement, these signals are converted into real actions using robotic assistive devices like a thought-controlled glove. Clinical trials of brain implant data show that 32 patients have already used it safely, without serious side effects.
China’s National Medical Products Administration has approved this commercial brain implant, making it the first market-ready device of its kind. While other companies like Neuralink continue experimental research, NEO has moved into early commercialization of neural technology. The approval positions China as a leader in global BCI research and highlights its ambitious strategy roadmap for neural innovation over the next five years.
Patients aged 19 to 60 with spinal cord or neck injuries can benefit from this paralysis cure technology. Studies confirm that brain implants for spinal cord injury patients improve mobility and independence, especially when combined with assistive robotics. Experts say the device demonstrates the safety and effectiveness of brain implants in restoring movement and improving quality of life.
In conclusion, the NEO brain implant represents a turning point for paralysis and neck injury recovery. China’s approval shows the potential of brain-computer interface technology to revolutionize neurological treatments and provide hope for millions worldwide.
